NeurAxis, Inc.

AMEX:NRXS

Biotechnology

Healthcare
$4.87 +4.25%

+$0.29 today

Market cap
$69.12M
Beta
1.41
P/E (TTM)
-10.5
EPS (TTM)
-$0.67
52W Low $2.20High $9.33

Volume 0.23M

Average 0.18M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$6.43M

FY 2025 · Annual

Investing Cash Flow

-$131,150.00

FY 2025 · Annual

Financing Cash Flow

$7.83M

FY 2025 · Annual

-19.6% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(3.03M)(4.78M)(14.63M)(8.24M)(7.8M)
Depreciation & Amortization36.71K37.13K40.73K37.83K59.5K
Deferred Income Tax41.11K0000
Stock-Based Compensation48.64K27.32K750K1.4M596.85K
Change in Working Capital644.43K1.27M(665.75K)141.4K610.12K
Accounts Receivables184.26K(78.6K)75.95K(178.85K)46.59K
Inventory67.67K(8.95K)26.91K(32.5K)(242.87K)
Accounts Payables319.23K1.11M(387.9K)(607.27K)(457.58K)
Other Working Capital73.28K249.62K(380.71K)960.02K1.26M
Other Non-Cash Items22.81K1.15M7.81M559.82K101.24K
Operating Cash Flow(2.23M)(2.3M)(6.69M)(6.1M)(6.43M)
Capital Expenditures(1.39K)(61.21K)(71.78K)(27.78K)(31.15K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities0(59.82K)(41K)0(100K)
Investing Cash Flow(1.39K)(61.21K)(71.78K)(27.78K)(131.15K)
Debt Repayment151.1K3.16M2.07M4.66M(281.75K)
Common Stock Issued510K04.85M08.83M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(510K)(866.74K)(322.9K)(168.32K)(712.67K)
Financing Cash Flow661.1K2.29M6.59M9.74M7.83M
Effect of Forex Changes00000
Net Change in Cash(1.57M)(67.16K)(175.14K)3.62M1.27M
Free Cash Flow(2.24M)(2.36M)(6.77M)(6.13M)(6.46M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$7.8M
+ D&A$59.5K
+ Stock-Based Comp$596.9K
+ Deferred Tax$0
+ Working Capital$610.1K
+ Other Non-Cash$101.2K
= Operating Cash Flow-$6.4M
- Capex-$31.1K
= Free Cash Flow-$6.5M

Analysis

FY2025 free cash flow is -$6.5M. FCF conversion is 82.9% of net income. Operating cash flow was -$6.4M, with capex of -$31.1K. The largest bridge item is Working Capital at $610.1K.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 10, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportOct 14, 2026
4Statement of changes in beneficial ownershipOct 8, 2026
4Statement of changes in beneficial ownershipOct 8, 2026

Does NRXS generate free cash flow?

NeurAxis, Inc. (NRXS) generated -$6.46M of free cash flow in fiscal 2025.

How much operating cash flow does NRXS produce?

Operating cash flow was -$6.43M, before capital expenditures of $31,150.00.